Company

  • Dec-2019
    As of December 2019, Merit Choice Bioengineering have achieved certification of 125 products.

  • Oct-2019
    In October 2019, Merit Choice Bioengineering released its new logo.

  • Sep-2019
    In September 2019, Baiding Investment Limited increased its total investment to US$ 10 Million.

  • Mar-2019
    In March 2019, Merit Choice Bioengineering established molecular diagnostic product laboratories.

  • Oct-2018
    In October 2018, Merit Choice Bioengineering signed a long-term strategic cooperation agreement with Beckman Coulter, Inc.

  • Jan-2018
    In January 2018, Baiding Investment Limited acquired all shares of Merit Choice Bioengineering, increasing its total investment to US$ 2 Million.

  • 2014
    In 2014, Merit Choice Bioengineering shut down the production of all types of dry powder dosage forms and accelerated the R&D of new types of liquid dosage forms. By 2014, Merit Choice Bioengineering had achieved certification of 63 products.

  • Oct-2012
    In October 2012, Merit Choice Bioengineering was elected as the director member of the Hai Dian District Pharmaceutical Industry Association of Beijing.

  • Jul-2012
    In July 2012, Merit Choice Bioengineering was certified as a demonstration company with the best management of ‘ten-million and above construction project’ and rated as one of the best companies with ‘three products and one machine’ in Beijing.

  • 2008
    In 2008, Merit Choice Bioengineering were certified with YY/T 0287 ISO 13485, IDT, and GB/T 19001 ISO 9001, IDT.

  • 2006
    In 2006, completed construction of the production base in Beijing Airport Industrial Zone C.

  • 2004
    In 2004, established wholly-owned subsidiary Beijing Kebaiquan Medical Devices Co., Ltd.

  • 2003
    In 2003, Merit Choice Bioengineering received the registration certificate for medical devices in seven categories, including liver and kidney diseases, issued by China’s State Food and Drug Administration.

  • 2002
    In 2002, Merit Choice Bioengineering was certified as High-Tech Enterprise.

  • 1994
    In 1994, Merit Choice Bioengineering’s first production facility was officially put in operation in Hai Dian District.

  • Sep-1993
    In September 1993, Merit Choice Bioengineering received medical device manufacturer license issued by Beijing Food and Drug Administration.

  • Jul-1993
    In July 1993, Merit Choice Bioengineering (Beijing) Co., Ltd. was founded.

  • Jun-1993
    In January 1993, founders received the permit of the companies funded by investors from Taiwan, Hong Kong and Macao.